Handelsbanken Fonder AB Buys 8,960 Shares of Cigna Group $CI

Handelsbanken Fonder AB lifted its stake in Cigna Group (NYSE:CI) by 12.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 82,825 shares of the health services provider’s stock after buying an additional 8,960 shares during the period. Handelsbanken Fonder AB’s holdings in Cigna Group were worth $22,833,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Evercore Wealth Management LLC lifted its holdings in shares of Cigna Group by 2.8% during the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock valued at $347,000 after acquiring an additional 35 shares during the period. Cary Street Partners Investment Advisory LLC grew its holdings in shares of Cigna Group by 11.0% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock worth $100,000 after purchasing an additional 36 shares during the last quarter. OLD National Bancorp IN grew its holdings in shares of Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after purchasing an additional 37 shares during the last quarter. IHT Wealth Management LLC increased its position in shares of Cigna Group by 2.5% during the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after purchasing an additional 38 shares in the last quarter. Finally, Whetstone Capital Advisors LLC increased its position in shares of Cigna Group by 4.9% during the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after purchasing an additional 39 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

Cigna Group stock opened at $277.57 on Thursday. The stock has a 50-day simple moving average of $286.23 and a 200 day simple moving average of $281.28. The stock has a market capitalization of $73.35 billion, a price-to-earnings ratio of 11.48, a P/E/G ratio of 0.94 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, research analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is 25.82%.

Insider Buying and Selling

In related news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on CI. UBS Group boosted their price target on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. The Goldman Sachs Group raised their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Finally, Robert W. Baird set a $362.00 price target on Cigna Group in a research report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.